News

After a Breakout Year for Digital Health, What’s Next? This week, I’m proud to join Canadian health system leaders in celebrating Digital Health Week — a time to recognize how digital health is transforming the delivery of care. When I think of the changes brought about by this pandemic, the “…
Today CADTH presented Recognition Awards to two scientists to honour their exceptional contributions to the field of health technology assessment (HTA) — one as a pioneer who has pushed the boundaries of economic evaluation in child health and the other as a rising star who is advancing the use of…
Beginning on Thursday, November 5th, we are changing our email notification process for all CADTH reimbursement reviews. The following milestones in all reimbursement reviews will now be communicated once per week in the new CADTH Weekly Summary: open calls for patient input and clinician input…
Today CADTH is proud to celebrate the first-ever World Evidence-Based Healthcare (EBHC) Day, a global initiative to highlight the critical role of evidence in improving health outcomes, enhancing clinical care, and informing policy. Organizations from around the world are using this day to…
CADTH is pleased to announce that we have resumed activities in our Scientific Advice Program. We are once again accepting applications for meetings that will be held in February 2021 and beyond. At this point, all meetings will be held virtually until further notice. Please keep in mind that time…
  We are pleased to announce that the CADTH Scientific Advice Program will resume activities on October 1, 2020. All Scientific Advice meetings will be held virtually until further notice. Applications for Scientific Advice meetings being planned in late February 2021 and onwards can be submitted…
In light of the COVID-19 pandemic, we’ve made some changes to our CADTH Scientific Advice Program activities. During this challenging and uncertain time, we recognize that clinical experts may not be available to participate in our projects. As input from Canadian clinical experts is key to…
Today CADTH has taken a significant step forward in making its Pharmaceutical Reviews program more cohesive, transparent, and responsive by establishing a harmonized review process for any drug product that is submitted to CADTH for assessment. Where there were previously unique procedures and…
International Overdose Awareness Day is a global day of awareness held every year on August 31. Today, I join millions of Canadians in reflecting on the lives lost due to overdose, the grief so many families endure, and the stigma that impacts the daily lives of people who use drugs. I’m also…
Deliberative processes in health technology assessment (HTA) were the focus of the 2020 HTAi Global Policy Forum; this new article summarizes the discussions that were held over two days in January. Dr. Nicole Mittmann, Chief Scientist and Vice-President of Evidence Standards at CADTH, was one of…
A new project on Flash Glucose Monitoring System FreeStyle Libre to Monitor Glycemia in Patients With Diabetes is now available for feedback from all interested stakeholders. Flash Glucose Monitoring System FreeStyle Libre to Monitor Glycemia in Patients With Diabetes Call for Feedback: 2020-07-…
CADTH is proud to welcome Suzanne McGurn, who begins her role as President and Chief Executive Officer today. Ms. McGurn was appointed by the CADTH Board of Directors after a comprehensive search that was international in scope. She brings to CADTH significant leadership experience and a deep…